Ryan Specialty Holdings, Inc. (NYSE:RYAN) Given Average Rating of “Hold” by Analysts

Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) have been given a consensus rating of “Hold” by the twelve analysts that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $74.40.

RYAN has been the topic of several recent research reports. Barclays boosted their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. Morgan Stanley initiated coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price objective on the stock. Keefe, Bruyette & Woods lowered their price target on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a research note on Friday, January 10th. Finally, Wells Fargo & Company decreased their price objective on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 14th.

Insider Activity

In related news, Director David P. Bolger sold 7,055 shares of Ryan Specialty stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total value of $500,058.40. Following the completion of the sale, the director now owns 78,149 shares in the company, valued at approximately $5,539,201.12. The trade was a 8.28 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction on Friday, December 13th. The stock was sold at an average price of $67.39, for a total transaction of $2,358,650.00. Following the completion of the transaction, the director now directly owns 65,100 shares of the company’s stock, valued at approximately $4,387,089. This represents a 34.97 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 323,506 shares of company stock worth $21,407,851 over the last 90 days. Company insiders own 11.10% of the company’s stock.

Hedge Funds Weigh In On Ryan Specialty

A number of hedge funds have recently added to or reduced their stakes in RYAN. Jennison Associates LLC boosted its holdings in shares of Ryan Specialty by 60.2% during the third quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock valued at $68,054,000 after acquiring an additional 385,366 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of Ryan Specialty by 107.5% during the third quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock valued at $30,504,000 after acquiring an additional 238,064 shares during the period. Geneva Partners LLC bought a new stake in shares of Ryan Specialty during the third quarter valued at about $2,537,000. Bar Harbor Wealth Management raised its stake in shares of Ryan Specialty by 5.9% during the fourth quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company’s stock valued at $10,835,000 after purchasing an additional 9,482 shares in the last quarter. Finally, Barclays PLC raised its stake in shares of Ryan Specialty by 1.1% during the third quarter. Barclays PLC now owns 1,641,743 shares of the company’s stock valued at $108,994,000 after purchasing an additional 17,267 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.

Ryan Specialty Stock Performance

Shares of Ryan Specialty stock opened at $66.70 on Wednesday. The firm’s fifty day simple moving average is $65.85 and its 200-day simple moving average is $67.03. The stock has a market capitalization of $17.47 billion, a price-to-earnings ratio of 86.63, a PEG ratio of 1.19 and a beta of 0.72. Ryan Specialty has a 12 month low of $43.26 and a 12 month high of $75.97. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.